Ahmedabad, India – May 6, 2025 – The U.S. subsidiary of Senores Pharmaceuticals Limited (“SPL”), Havix Group Inc. D/B/A Aavis Pharmaceuticals, announces the appointment of Mr. Gautam Shah as President of U.S. Operations. This strategic move underscores the company’s commitment to expanding its footprint in the regulated U.S. market.
Mr. Shah brings over three decades of experience in the pharmaceutical industry, including 10 years in India and 20 years in the United States. His illustrious career includes senior roles at renowned pharmaceutical companies such as Cipla and Sun Pharma in India and Sun Pharma, Zydus Lifesciences, Intas Pharmaceuticals, Dow Corning Corp., and Med-Pharmex in the U.S. His expertise spans quality assurance, compliance, operations management, manufacturing, and leadership.
Mr. Shah holds a bachelor’s degree in pharmacy, a postgraduate diploma in business administration, and is a certified Six Sigma Black Belt. As President of US Operations, he will lead our entire group’s US operations and will be instrumental in future expansion.
